[go: up one dir, main page]

MX2010009453A - Soluciones de topotecano listas para utilizarse. - Google Patents

Soluciones de topotecano listas para utilizarse.

Info

Publication number
MX2010009453A
MX2010009453A MX2010009453A MX2010009453A MX2010009453A MX 2010009453 A MX2010009453 A MX 2010009453A MX 2010009453 A MX2010009453 A MX 2010009453A MX 2010009453 A MX2010009453 A MX 2010009453A MX 2010009453 A MX2010009453 A MX 2010009453A
Authority
MX
Mexico
Prior art keywords
topotecan
ready
use solutions
formulations
hcpt
Prior art date
Application number
MX2010009453A
Other languages
English (en)
Inventor
Philip Christopher Buxton
Bulusu Bhanu Teja
Nagesh R Palepu
Original Assignee
Eagle Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eagle Pharmaceuticals Inc filed Critical Eagle Pharmaceuticals Inc
Publication of MX2010009453A publication Critical patent/MX2010009453A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen formulaciones que contienen topotecano listas para utilizarse, basadas en agua; las formulaciones están de manera sorprendente, libre de los productos de la degradación precipitados, tales como 10-hidroxicamptotecina (10-HCPT) después de periodos de hasta 1 años o mayores.
MX2010009453A 2008-02-29 2009-02-27 Soluciones de topotecano listas para utilizarse. MX2010009453A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3265208P 2008-02-29 2008-02-29
PCT/US2009/035421 WO2009111294A1 (en) 2008-02-29 2009-02-27 Topotecan ready to use solutions

Publications (1)

Publication Number Publication Date
MX2010009453A true MX2010009453A (es) 2011-03-01

Family

ID=41013658

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010009453A MX2010009453A (es) 2008-02-29 2009-02-27 Soluciones de topotecano listas para utilizarse.

Country Status (7)

Country Link
US (1) US20090221622A1 (es)
EP (1) EP2259776A4 (es)
JP (1) JP5579083B2 (es)
CN (1) CN101969926A (es)
CA (1) CA2715832A1 (es)
MX (1) MX2010009453A (es)
WO (1) WO2009111294A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2056675T (pt) 2006-10-12 2019-05-09 Galera Labs Llc Métodos de tratamento da mucosite oral
EP2430141B1 (en) 2009-05-12 2017-01-18 Ecolab Usa Inc. Fast drying and fast draining rinse aid
CN103906756B (zh) 2011-09-26 2020-03-03 加莱拉实验室有限责任公司 用于治疗疾病的方法
US10098813B2 (en) 2014-09-03 2018-10-16 Sun Pharmaceutical Industries Limited Perfusion dosage form
JP7041959B2 (ja) 2015-08-11 2022-03-25 ガレラ・ラブス・リミテッド・ライアビリティ・カンパニー 経口バイオアベイラビリティを有するペンタアザ大環状環錯体
CN109069342A (zh) 2016-02-09 2018-12-21 太阳医药工业有限公司 灌注系统
WO2017192740A2 (en) 2016-05-03 2017-11-09 Galera Labs, Llc Combination therapy for cancer treatment
AU2017318718B2 (en) 2016-09-01 2023-06-29 Galera Labs, Llc Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
IL295620B2 (en) 2017-04-13 2024-01-01 Galera Labs Llc Combination cancer immunotherapy with pentaaza macrocyclic ring complex

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
JP2007522085A (ja) * 2003-06-27 2007-08-09 スミスクライン・ビーチャム・コーポレイション 安定化されたトポテカンリポソーム組成物および方法
NZ580516A (en) * 2007-04-19 2012-02-24 Scinopharm Taiwan Ltd Crystalline forms of topotecan hydrochloride and processes for making the same

Also Published As

Publication number Publication date
US20090221622A1 (en) 2009-09-03
WO2009111294A1 (en) 2009-09-11
EP2259776A1 (en) 2010-12-15
CN101969926A (zh) 2011-02-09
JP5579083B2 (ja) 2014-08-27
CA2715832A1 (en) 2009-09-11
JP2011513333A (ja) 2011-04-28
EP2259776A4 (en) 2011-03-16

Similar Documents

Publication Publication Date Title
MX2010009453A (es) Soluciones de topotecano listas para utilizarse.
TW201129565A (en) Tricyclic heterocyclic compounds, compositions and methods of use thereof
PH12014500813A1 (en) Novel [1,2,3] triazolo [4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor
HK1211208A1 (zh) 細胞毒性苯並二氮呯衍生物
WO2010004197A3 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
IN2012DN01641A (es)
MX2010004493A (es) Compuestos de tropano.
UA114656C2 (uk) Похідні піридину
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.
PH12014501026A1 (en) [1, 2, 3]triazolo[4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 agonists
NZ594186A (en) Indole derivatives as anticancer agents
IN2012DN01642A (es)
WO2010027424A3 (en) 9-substituted phenanthrene based tylophorine derivatives
MX2013006418A (es) Derivados de oxazolil-metileter como agonistas del receptor de alx.
EP2129672A4 (en) ESTER AND CARBAMATE AZAADAMANTANE DERIVATIVES AND METHODS OF USE
PH12012501125A1 (en) 3, 4, 4a, 10b - tetrahydro -1h- thiopyrano -[4, 3-c] isoquinoline derivatives
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
TN2011000355A1 (en) Novel microbiocides
HK1200392A1 (en) Acetaminophen conjugates, compositions and methods of use thereof
WO2009047634A3 (en) Aqueous formulations of acetaminophen for injection
IN2012DN01223A (es)
IN2012DN02698A (es)
WO2009081283A3 (en) Aqueous formulations of acetaminophen for injection
WO2009124723A3 (en) Novel aureothin derivatives